STRADVISION Approaches 5 million Unit Milestone, Marking a Year of Significant Global Commercial Expansion
Cumulative SVNet Deployment Nears 5 Million Vehicles Worldwide Significant volume deployed in 2025, reflecting strong commercial momentum Growth Driven by Multi-Year Business Maturation and Expanded Mass Production Programs SEOUL, South Korea and...
World's First Serum-Free Iterative Rabies Vaccine from AIM Successfully Passes On-Site Registration Inspections and Is Imminent for Launch
HONG KONG, Feb. 6, 2026 /PRNewswire/ -- Poised to Fill the Global Market Gap, the Serum-Free Iterative Rabies Vaccine Approaches a Critical Milestone in Commercialization. AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on...